FAF-Drugs3: A web server for compound property calculation and chemical library design

Nucleic Acids Research

Volumn 43, Issue W1, 2015, Pages W200-W207

  Lagorce, David ^a,b   Sperandio, Olivier ^a,b   Baell, Jonathan B ^c   Miteva, Maria A ^a,b   Villoutreix, Bruno O ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; BIOCHEMISTRY; COMPUTER INTERFACE; DECISION MAKING; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG INFORMATION; DRUG METABOLISM; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TOXICITY; INTERNET; LIBRARY; ONLINE ANALYSIS; ONLINE SYSTEM; PHARMACOLOGICAL PROCEDURES; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REGISTRATION; STRUCTURE ANALYSIS; CHEMISTRY; COMPUTER PROGRAM; DRUG DEVELOPMENT; PHARMACOKINETICS;

DRUG;

DRUG DISCOVERY; INTERNET; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SOFTWARE;

EID: 84979854830     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv353     Document Type: Article

References (52)

1. Keseru, G.M. and Makara, G.M. (2009) The influence of lead discovery strategies on the properties of drug candidates. Nat. Rev. Drug Discov., 8, 203-212.
2. Cumming, J.G., Davis, A.M., Muresan, S., Haeberlein, M. and Chen, H. (2013) Chemical predictive modelling to improve compound quality. Nat. Rev. Drug Discov., 12, 948-962.
3. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
4. Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I.H., Frearson, J. and Wyatt, P.G. (2008) Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. Chem Med Chem, 3, 435-444.
5. Workman, P. and Collins, I. (2010) Probing the probes: fitness factors for small molecule tools. Chem. Biol., 17, 561-577.
6. Doak, B.C., Over, B., Giordanetto, F. and Kihlberg, J. (2014) Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem. Biol., 21, 1115-1142.
7. Mok, N.Y., Maxe, S. and Brenk, R. (2013) Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries. J. Chem. Inf. Model., 53, 534-544.
8. Blagg, J. (2010) Structural Alerts for Toxicity. In: Abraham, DJ and Rotella, DP (eds). Burger's Medicinal Chemistry, Drug Discovery, and Development. 7th edn. John Wiley & Sons, Inc, NJ, 301-334.
9. Gleeson, M.P. (2008) Generation of a set of simple, interpretable ADMET rules of thumb. J. Med. Chem., 51, 817-834.
10. Hughes, J.D., Blagg, J., Price, D.A., Bailey, S., Decrescenzo, G.A., Devraj, R.V., Ellsworth, E., Fobian, Y.M., Gibbs, M.E., Gilles, R.W. et al. (2008) Physiochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett., 18, 4872-4875.
11. Lovering, F., Bikker, J. and Humblet, C. (2009) Escape from flatland: increasing saturation as an approach to improving clinical success. J. Med. Chem., 52, 6752-6756.
12. Bruns, R.F. and Watson, I.A. (2012) Rules for identifying potentially reactive or promiscuous compounds. J. Med. Chem., 55, 9763-9772.
13. Stepan, A.F., Walker, D.P., Bauman, J., Price, D.A., Baillie, T.A., Kalgutkar, A.S. and Aleo, M.D. (2011) Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem. Res. Toxicol., 24, 1345-1410.
14. Benigni, R. and Bossa, C. (2011) Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chem. Rev., 111, 2507-2536.
15. Enoch, S.J., Ellison, C.M., Schultz, T.W. and Cronin, M.T. (2011) A review of the electrophilic reaction chemistry involved in covalent protein binding relevant to toxicity. Crit. Rev. Toxicol., 41, 783-802.
16. Kalgutkar, A.S., Gardner, I., Obach, R.S., Shaffer, C.L., Callegari, E., Henne, K.R., Mutlib, A.E., Dalvie, D.K., Lee, J.S., Nakai, Y. et al. (2005) A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab., 6, 161-225.
17. Baell, J. and Walters, M.A. (2014) Chemistry: chemical con artists foil drug discovery. Nature, 513, 481-483.
18. Baell, J.B. and Holloway, G.A. (2010) New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem., 53, 2719-2740.
19. McGovern, S.L., Caselli, E., Grigorieff, N. and Shoichet, B.K. (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J. Med. Chem., 45, 1712-1722.
20. Drwal, M.N., Banerjee, P., Dunkel, M., Wettig, M.R. and Preissner, R. (2014) Pro Tox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res., 42, W53-W58.
21. Villoutreix, B.O., Lagorce, D., Labbe, C.M., Sperandio, O. and Miteva, M.A. (2013) One hundred thousand mouse clicks down the road: selected online resources supporting drug discovery collected over a decade. Drug Discov. Today, 18, 1081-1089.
22. Miteva, M.A., Violas, S., Montes, M., Gomez, D., Tuffery, P. and Villoutreix, B.O. (2006) FAF-Drugs: free ADME/tox filtering of compound collections. Nucleic Acids Res., 34, W738-W744.
23. Lagorce, D., Maupetit, J., Baell, J., Sperandio, O., Tuffery, P., Miteva, M.A., Galons, H. and Villoutreix, B.O. (2011) The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections. Bioinformatics, 27, 2018-2020.
24. Przybylak, K.R., Alzahrani, A.R. and Cronin, M.T. (2014) How does the quality of phospholipidosis data influence the predictivity of structural alerts? J. Chem. Inf. Model., 54, 2224-2232.
25. Neron, B., Menager, H., Maufrais, C., Joly, N., Maupetit, J., Letort, S., Carrere, S., Tuffery, P. and Letondal, C. (2009) Mobyle: a new full web bioinformatics framework. Bioinformatics, 25, 3005-3011.
26. O'Boyle, N.M., Morley, C. and Hutchison, G.R. (2008) Pybel: a Python wrapper for the Open Babel cheminformatics toolkit. Chem. Cent. J., 2, 5-12.
27. Miteva, M.A., Guyon, F. and Tuffery, P. (2010) Frog2: efficient 3D conformation ensemble generator for small compounds. Nucleic Acids Res., 38, W622-W627.
28. Pihan, E., Colliandre, L., Guichou, J.F. and Douguet, D. (2012) e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics, 28, 1540-1541.
29. Cheng, T., Zhao, Y., Li, X., Lin, F., Xu, Y., Zhang, X., Li, Y., Wang, R. and Lai, L. (2007) Computation of octanol-water partition coefficients by guiding an additive model with knowledge. J. Chem. Inf. Model., 47, 2140-2148.
30. Ertl, P., Rohde, B. and Selzer, P. (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem., 43, 3714-3717.
31. Congreve, M., Carr, R., Murray, C. and Jhoti, H. (2003) A 'rule of three' for fragment-based lead discovery? Drug Discov. Today, 8, 876-877.
32. Charifson, P.S. and Walters, W.P. (2002) Filtering databases and chemical libraries. Mol. Divers., 5, 185-197.
33. Irwin, J.J. and Shoichet, B.K. (2005) ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 45, 177-182.
34. Jeffrey, P. and Summerfield, S. (2010) Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol. Dis., 37, 33-37.
35. Ritchie, T.J., Luscombe, C.N. and Macdonald, S.J. (2009) Analysis of the calculated physicochemical properties of respiratory drugs: can we design for inhaled drugs yet? J. Chem. Inf. Model., 49, 1025-1032.
36. Oprea, T.I. (2000) Property distribution of drug-related chemical databases. J. Comput. Aided Mol. Des., 14, 251-264.
37. Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W. and Kopple, K.D. (2002) Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem., 45, 2615-2623.
38. Egan, W.J., Merz, K.M. Jr and Baldwin, J.J. (2000) Prediction of drug absorption using multivariate statistics. J. Med. Chem., 43, 3867-3877.
39. Lobell, M., Hendrix, M., Hinzen, B., Keldenich, J., Meier, H., Schmeck, C., Schohe-Loop, R., Wunberg, T. and Hillisch, A. (2006) In silico ADMET traffic lights as a tool for the prioritization of HTS hits. Chem Med Chem, 1, 1229-1236.
40. Chevillard, F., Lagorce, D., Reynes, C., Villoutreix, B.O., Vayer, P. and Miteva, M.A. (2012) In silico prediction of aqueous solubility: a multimodel protocol based on chemical similarity. Mol. Pharm., 9, 3127-3135.
41. Wang, J. and Hou, T. (2011) Recent advances on aqueous solubility prediction. Comb. Chem. High Throughput Screen., 14, 328-338.
42. Delaney, J.S. (2004) ESOL: estimating aqueous solubility directly from molecular structure. J. Chem. Inf. Comput. Sci., 44, 1000-1005.
43. Hill, A.P. and Young, R.J. (2010) Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity. Drug Discov. Today, 15, 648-655.
44. Reynes, C., Host, H., Camproux, A.C., Laconde, G., Leroux, F., Mazars, A., Deprez, B., Fahraeus, R., Villoutreix, B.O. and Sperandio, O. (2010) Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods. PLoS Comput. Biol., 6, e1000695.
45. Labbe, C.M., Laconde, G., Kuenemann, M.A., Villoutreix, B.O. and Sperandio, O. (2013) iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions. Drug Discov. Today, 18, 958-968.
46. Pearce, B.C., Sofia, M.J., Good, A.C., Drexler, D.M. and Stock, D.A. (2006) An empirical process for the design of high-throughput screening deck filters. J. Chem. Inf. Model., 46, 1060-1068.
47. Ashby, J., Basketter, D.A., Paton, D. and Kimber, I. (1995) Structure activity relationships in skin sensitization using the murine local lymph node assay. Toxicology, 103, 177-194.
48. Schomburg, K., Ehrlich, H.C., Stierand, K. and Rarey, M. (2010) From structure diagrams to visual chemical patterns. J. Chem. Inf. Model., 50, 1529-1535.
49. Bolton, E. and W.Y.W.Y., Thiessen, P.A. and Bryant, S.H. (2008) Annual Reports in Computational Chemistry, American Chemical Society, Washington, DC, Vol. 4.
50. Roche, O., Schneider, P., Zuegge, J., Guba, W., Kansy, M., Alanine, A., Bleicher, K., Danel, F., Gutknecht, E.M., Rogers-Evans, M. et al. (2002) Development of a virtual screening method for identification of 'frequent hitters' in compound libraries. J. Med. Chem., 45, 137-142.
51. Devine, S.M., Mulcair, M.D., Debono, C.O., Leung, E.W., Nissink, J.W., Lim, S.S., Chandrashekaran, I.R., Vazirani, M., Mohanty, B., Simpson, J.S. et al. (2015) Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. J. Med. Chem, 58, 1205-1214.
52. Rishton, G.M. (2008) Aggregator compounds confound amyloid fibrillization assay. Nat. Chem. Biol., 4, 159-160.